Search Results 1801-1810 of 19552 for hemoglobin

1. Study to Compare the Safety and Effectiveness of Treatment Combinations in Patients with Recurrent Ovarian Cancer - Mayo Clinic

   Hemoglobin ≥9 g/dL without transfusion or growth factor (recombinant erythropoietin) within 2 weeks of screening;; Serum creatinine ≤ 1.5 × upper limit of ...

2. A Study Of SPX-303, A Bispecific Antibody Targeting LILRB2 And PD-L1 In Patients With Solid Tumors - Mayo Clinic

   Adequate hematological function: absolute neutrophil count (ANC) ≥1 x 10\^9/L; platelets ≥75 x 10\^9/L, hemoglobin ≥9 g/dL. 10. Patients with well ...

3. Mayo Clinic Minute: Are supplements safe for cancer patients?

   If you've been diagnosed with cancer, you may be considering taking herbal and dietary supplements to help strengthen your immune system and ease the ...

4. Mayo Clinic Minute: It's hard to beat the health benefits of beets

   Beets are bright red root vegetables, and they are gaining popularity in the health field. In addition to being low-calorie, they're also loaded with nutrients ...

5. Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   ... hemoglobin\] ≥ 25% to \<80% of predicted normal. Exclusion Criteria: 1. Relevant airways obstruction (pre-bronchodilator Forced Expiratory Volume in one ...

6. Neurology - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

7. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

   Hemoglobin > 9 g/dL without transfusion or erythropoiesis stimulating agents dependency; Serum creatinine ≤ 1.5 x upper limit of normal (ULN); Total serum ...

8. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

   Hemoglobin ≤ 9.5 g/dL. Absolute neutrophil count < 1,000 per mm^3. History of known anti-GM-CSF autoAb or tests positive at screening, or history of ...

9. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Creatinine ≤ 2 x ULN;; SGOT (AST) ≤ 2 x ULN;; Albumin ≥ 3 g/dL. Willing and able to swallow capsules. Willing and able to complete ...

10. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

    * Hemoglobin \>= 8.0 g/dL (=\< 14 days prior to registration) * Absolute neutrophil count (ANC) \>= 500/mm\^3 (=\< 14 days prior to registration) * Platelet ...